HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tuuli Sedman Selected Research

Glucagon-Like Peptide 1 (GLP 1)

10/2020Tolerance develops toward GLP-1 receptor agonists' glucose-lowering effect in mice.
1/2016Exenatide Is an Effective Antihyperglycaemic Agent in a Mouse Model of Wolfram Syndrome 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tuuli Sedman Research Topics

Disease

2Hypoglycemia (Reactive Hypoglycemia)
10/2020 - 01/2017
1Wolfram Syndrome (Syndrome, Wolfram)
01/2016

Drug/Important Bio-Agent (IBA)

2Glucagon-Like Peptide 1 (GLP 1)IBA
10/2020 - 01/2016
2Glucose (Dextrose)FDA LinkGeneric
10/2020 - 01/2017
2Hypoglycemic Agents (Hypoglycemics)IBA
10/2020 - 01/2017
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2017
1Glipizide (Glucotrol)FDA LinkGeneric
01/2016
1Glucagon-Like Peptide-1 ReceptorIBA
01/2016
1Exenatide (Byetta)FDA Link
01/2016
1Insulin SecretagoguesIBA
01/2016